Identifying Metabolites in Ovarian Cancer
Author Information
Author(s): Fong Miranda Y., McDunn Jonathan, Kakar Sham S.
Primary Institution: University of Louisville
Hypothesis
This study aims to characterize the metabolome of the human ovary and identify metabolic alterations associated with primary and metastatic ovarian cancer.
Conclusion
The study found significant metabolic changes in ovarian cancer that could serve as potential biomarkers for diagnosis and treatment.
Supporting Evidence
- 364 biochemicals were identified in the ovarian metabolome.
- Significant changes in energy utilization were detected in ovarian cancer.
- Enhanced oxidative stress response was observed in cancerous tissues.
Takeaway
Researchers looked at the chemicals in ovaries and found changes that happen when cancer is present, which could help doctors find and treat ovarian cancer better.
Methodology
The study used gas chromatography mass spectrometry (GC/MS) and liquid chromatography tandem mass spectrometry (LC/MS/MS) to analyze ovarian tissue samples.
Potential Biases
Potential bias due to the small sample size and the specific population from which samples were obtained.
Limitations
The study's findings need validation in larger cohorts to confirm the clinical utility of identified metabolites.
Participant Demographics
The study included 12 normal ovarian samples, 11 primary ovarian adenocarcinomas, and 7 metastatic tumors, with mean ages ranging from 48.6 to 62 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website